Pharmaceutical Supply – Metoprolol Succinate Extended-Release Tablets

The contract calls for the supply of 2,000 units of Metoprolol Succinate Extended-Release Tablets, 100 mg, to be delivered in full compliance with Department of Defense Medical Supply Chain standards, including proper packaging and labeling as required. The specified place of performance is Fort Stewart, Georgia, with the ZIP code 31314-5185, ensuring the product reaches the designated military medical facility. The contract falls under NAICS code 325412, indicating pharmaceutical manufacturing, and is classified as a subcontract within the broader DOD procurement framework. All offerings must meet strict regulatory and quality controls aligned with federal pharmaceutical guidelines to ensure patient safety and operational readiness. The solicitation was posted on July 27, 2026, with a response deadline set for August 3, 2026, allowing potential vendors a limited window to submit proposals. While no specific set-aside designation is noted, the contract is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, emphasizing the critical nature of the medication for military personnel. Delivery timelines, documentation accuracy, and adherence to DLA specifications are paramount, and the vendor must be prepared to meet all federal pharmaceutical handling and distribution requirements without exception. The official procurement portal for this opportunity is accessible via the provided DIBBS link.